EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Slit2/Robo1 signaling inhibits small‐cell lung cancer by targeting β‐catenin signaling in tumor cells and macrophages

Dinesh K Ahirwar, Bo Peng, Manish Charan, Swati Misri, Sanjay Mishra, Kirti Kaul, Salha Sassi, Venkat Sundar Gadepalli, Jalal Siddiqui, Wayne O Miles, Ramesh K Ganju iD

Molecular Oncology · 2023

DOI: 10.1002/1878-0261.13289 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Oncology, 2023. Verfasst von Dinesh K Ahirwar und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, College of Medicine, The Ohio State University, Columbus, OH, USA. Hauptthemen laut MEDLINE: Small Cell Lung Carcinoma, Lung Neoplasms. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 86 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, National Cancer Institute, U.S. Department of Defense.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Small‐cell lung cancer (SCLC) is an aggressive neuroendocrine subtype of lung cancer with poor patient prognosis. However, the mechanisms that regulate SCLC progression and metastasis remain undefined. Here, we show that the expression of the slit guidance ligand 2 ( SLIT2 ) tumor suppressor gene is reduced in SCLC tumors relative to adjacent normal tissue. In addition, the expression of the SLIT2 receptor, roundabout guidance receptor 1 ( ROBO1 ), is upregulated. We find a positive association between SLIT2 expression and the Yes1 associated transcriptional regulator ( YAP1 )‐expressing SCLC subtype (SCLC‐Y), which shows a better prognosis. Using genetically engineered SCLC cells, adenovirus gene therapy, and preclinical xenograft models, we show that SLIT2 overexpression or the deletion of ROBO1 restricts tumor growth in vitro and in vivo . Mechanistic studies revealed significant inhibition of myeloid‐derived suppressor cells (MDSCs) and M2‐like tumor‐associated macrophages (TAMs) in the SCLC tumors. In addition, SLIT2 enhances M1‐like and phagocytic macrophages. Molecular analysis showed that ROBO1 knockout or SLIT2 overexpression suppresses the transforming growth factor beta 1 (TGF‐β1)/β‐catenin signaling pathway in both tumor cells and macrophages. Overall, we find that SLIT2 and ROBO1 have contrasting effects on SCLC tumors. SLIT2 suppresses, whereas ROBO1 promotes, SCLC growth by regulating the Tgf‐β1/glycogen synthase kinase‐3 beta (GSK3)/β‐catenin signaling pathway in tumor cells and TAMs. These studies indicate that SLIT2 could be used as a novel therapeutic agent against aggressive SCLC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Small Cell Lung CarcinomaLung NeoplasmsHumansTransforming Growth Factor beta1beta CateninNerve Tissue ProteinsGlycogen Synthase Kinase 3Receptors, ImmunologicSignal TransductionMacrophages

Stichwörter der Autor:innen

MDSCsRobo1Slit2TAMssmall-cell lung cancer

Substanzen

Transforming Growth Factor beta1beta CateninNerve Tissue ProteinsGlycogen Synthase Kinase 3Receptors, Immunologic

Autor:innen und Institutionen

  • Department of Pathology, College of Medicine, The Ohio State University, Columbus, OH, USA.
  • Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USA.
  • Department of Bioscience & Bioengineering, Indian Institute of Technology, Jodhpur, India.
  • Biomedical Informatics, The Ohio State University, Columbus, OH, USA.
  • Department of Cancer Biology and Genetics, The Ohio State University, Columbus, OH, USA.

ORCID-Profile: Ramesh K Ganju

Förderung

  • NCI NIH HHS
  • National Cancer Institute
  • U.S. Department of Defense
  • Comprehensive Cancer Center, City of Hope

Zitieren

APA

Ahirwar, D. K., Peng, B., Charan, M., Misri, S., Mishra, S., Kaul, K., Sassi, S., Gadepalli, V. S., Siddiqui, J., Miles, W. O., & Ganju, R. K. (2023). Slit2/Robo1 signaling inhibits small‐cell lung cancer by targeting β‐catenin signaling in tumor cells and macrophages. Molecular Oncology. https://doi.org/10.1002/1878-0261.13289

Vancouver

Ahirwar DK, Peng B, Charan M, Misri S, Mishra S, Kaul K, et al. Slit2/Robo1 signaling inhibits small‐cell lung cancer by targeting β‐catenin signaling in tumor cells and macrophages. Molecular Oncology. 2023. doi:10.1002/1878-0261.13289

BibTeX
@article{Ahirwar2023,
  author = {Ahirwar, Dinesh K and Peng, Bo and Charan, Manish and Misri, Swati and Mishra, Sanjay and Kaul, Kirti and Sassi, Salha and Gadepalli, Venkat Sundar and Siddiqui, Jalal and Miles, Wayne O and Ganju, Ramesh K},
  title = {Slit2/Robo1 signaling inhibits small‐cell lung cancer by targeting β‐catenin signaling in tumor cells and macrophages},
  journal = {Molecular Oncology},
  year = {2023},
  doi = {10.1002/1878-0261.13289}
}
Kostenlos starten →